Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2017 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Installed Capacity - Large Volume Parenterals (LVP) Lakh Bottles per Annum ・Standalone data |
|
|||||
| Installed Capacity - Small Volume Parenterals (SVP) Lakh Bottles per Annum ・Standalone data |
||||||
| Capacity Utilization - Total % ・Standalone data |
||||||
| Commercialized Products (Portfolio Size) Count ・Standalone data |
||||||
| Capacity Utilization - LVP % ・Standalone data |
||||||
| Capacity Utilization - SteriPort % ・Standalone data |
||||||
| Capacity Utilization - SVP % ・Standalone data |
||||||
| Installed Capacity - SteriPort Lakh Bottles per Annum ・Standalone data |
||||||
| Total Workforce (Employees + Contractual) Count ・Standalone data |
||||||
| Number of Distributors Count ・Standalone data |
||||||
| Product Registrations (International) Count ・Standalone data |
||||||
Extracted by Screener AI
Documents
Announcements
-
Intimation For Commissioning Of Solar Power Plant For Captive
Consumption
1d - 10.8 MWp solar power plant commissioned in Kheda; generation started May 30, 2026 for captive use.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - Amanta Healthcare filed FY26 secretarial compliance report; no major non-compliances noted.
-
Statement Of Deviation Or Variation In Utilization Of Funds, If Any
2d - No deviation in use of ₹126 crore IPO proceeds for quarter ended December 31, 2025.
-
Statement Of Deviation Or Variation In Utilization Of Funds, If Any.
2d - Reported no deviation in IPO proceeds for quarter ended March 31, 2026; ₹126 crore raised.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 21 May
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT
Business Profile[1][2]
Amanta Healthcare manufactures sterile liquid products, mainly parenteral medications administered through injections or infusions. Their production utilizes advanced technologies such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM). The company operates in six therapeutic areas, including fluid therapy, ophthalmics, respiratory care, and irrigation solutions, plus a medical device segment.